Vietnam AI Life Science Analytics Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Vietnam AI Life Science Analytics Market, valued at USD 85 million, is growing due to AI integration in healthcare, predictive analytics dominance, and national AI strategy until 2030.

Region:Asia

Author(s):Geetanshi

Product Code:KRAA0607

Pages:97

Published On:January 2026

About the Report

Base Year 2024

Vietnam AI Life Science Analytics Market Overview

  • The Vietnam AI Life Science Analytics Market is valued at USD 85 million, based on a five-year historical analysis. This growth is primarily driven by the increasing adoption of AI technologies in healthcare, the rising demand for personalized medicine, the need for efficient data management in life sciences, and expanding healthcare expenditure alongside multinational biopharma investments in the region. The integration of AI in research and development processes has significantly enhanced the capabilities of healthcare providers and pharmaceutical companies.
  • Key cities such as Ho Chi Minh City and Hanoi dominate the Vietnam AI Life Science Analytics Market due to their robust healthcare infrastructure, presence of leading research institutions, and a growing number of tech startups focusing on AI solutions. These urban centers are pivotal in fostering innovation and attracting investments, which further propels the market's growth.
  • The National Strategy on Research, Development and Application of Artificial Intelligence until 2030, approved by the Prime Minister of Vietnam in 2021, promotes the application of AI in healthcare through dedicated programs requiring public institutions and enterprises to integrate AI solutions with minimum annual investments in R&D equivalent to 1-2% of revenue. This strategy mandates compliance via annual reporting to the Ministry of Science and Technology, covering AI deployment in healthcare for diagnostics, treatment optimization, and operational management.
Vietnam AI Life Science Analytics Market Size

Vietnam AI Life Science Analytics Market Segmentation

By Type:

Vietnam AI Life Science Analytics Market segmentation by Type.

The market is segmented into three types: Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics. Among these, Predictive Analytics is currently the leading sub-segment, driven by its ability to forecast patient outcomes and optimize treatment plans. The increasing reliance on data-driven decision-making in healthcare has led to a surge in demand for predictive models that can analyze vast datasets to identify trends and improve patient care. As healthcare providers seek to enhance operational efficiencies and patient satisfaction, the adoption of predictive analytics continues to rise.

By Component:

Vietnam AI Life Science Analytics Market segmentation by Component.

This segmentation includes Software and Services. The Software sub-segment is leading the market, primarily due to the increasing demand for advanced analytics tools that facilitate data processing and visualization. As healthcare organizations strive to improve their data management capabilities, the need for sophisticated software solutions has become paramount. Additionally, the rise of cloud-based software solutions has made it easier for organizations to adopt and integrate these technologies into their existing systems.

Vietnam AI Life Science Analytics Market Competitive Landscape

The Vietnam AI Life Science Analytics Market is characterized by a dynamic mix of regional and international players. Leading participants such as IQVIA, Oracle, Accenture, Cognizant, Wipro, Thermo Fisher Scientific, Illumina, Invitae, Siemens Healthineers, SAP, Infosys, FujiFilm, VinBigData, FPT Corporation, Viettel Group contribute to innovation, geographic expansion, and service delivery in this space.

IQVIA

2016

Durham, North Carolina, USA

Oracle

1977

Redwood City, California, USA

Accenture

1989

Dublin, Ireland

Cognizant

1994

Teaneck, New Jersey, USA

Wipro

1945

Bangalore, India

Company

Establishment Year

Headquarters

Year of Establishment

Revenue (USD Million)

Revenue Growth Rate (CAGR %)

Market Share (%)

Geographic Presence

Product Portfolio

Vietnam AI Life Science Analytics Market Industry Analysis

Growth Drivers

  • Increasing Demand for Personalized Medicine:The Vietnamese healthcare sector is witnessing a surge in demand for personalized medicine, driven by a population of over 99 million. In future, the healthcare expenditure is projected to reach approximately $22 billion, reflecting a growing inclination towards tailored treatment options. This trend is supported by the increasing prevalence of chronic diseases, with over 15 million cases reported, necessitating advanced analytics to optimize treatment plans and improve patient outcomes.
  • Advancements in AI Technologies:Vietnam's investment in AI technologies is expected to exceed $1.2 billion in future, fostering innovation in life sciences. The country has seen a 35% increase in AI startups focusing on healthcare solutions, enhancing data processing capabilities. These advancements enable healthcare providers to leverage machine learning algorithms for predictive analytics, improving diagnostic accuracy and treatment efficiency, which is crucial for addressing the rising healthcare demands of the population.
  • Government Support for Healthcare Innovation:The Vietnamese government allocated $600 million in future to promote healthcare innovation, including AI life science analytics. This funding supports research and development initiatives, aiming to enhance healthcare delivery systems. Additionally, the government is implementing policies to encourage public-private partnerships, which are expected to increase the adoption of AI technologies in healthcare, ultimately improving patient care and operational efficiency across the sector.

Market Challenges

  • Data Privacy Concerns:As the AI life science analytics market expands, data privacy remains a significant challenge. In future, Vietnam's healthcare sector is expected to handle over 1.2 billion patient records, raising concerns about data security and compliance with regulations. The lack of robust data protection frameworks may hinder the adoption of AI technologies, as stakeholders fear potential breaches and misuse of sensitive health information, impacting patient trust and industry growth.
  • High Implementation Costs:The initial costs associated with implementing AI solutions in healthcare can be prohibitive. In future, the average expenditure for AI integration in Vietnamese healthcare facilities is projected to be around $2.5 million per facility. This financial barrier can deter smaller healthcare providers from adopting advanced analytics, limiting the overall market growth. Additionally, ongoing maintenance and training costs further exacerbate the financial challenges faced by these institutions.

Vietnam AI Life Science Analytics Market Future Outlook

The future of the Vietnam AI life science analytics market appears promising, driven by technological advancements and increasing healthcare demands. In future, the integration of AI in diagnostics and treatment planning is expected to enhance patient outcomes significantly. Furthermore, the expansion of telemedicine services will facilitate remote patient monitoring, allowing for real-time data analytics. As the government continues to support healthcare innovation, collaboration between tech companies and healthcare providers will likely accelerate the adoption of AI solutions, transforming the healthcare landscape.

Market Opportunities

  • Expansion of Telemedicine Services:The telemedicine market in Vietnam is projected to grow to $2 billion in future, presenting significant opportunities for AI integration. This growth will enhance remote patient monitoring and data collection, allowing healthcare providers to utilize AI analytics for improved decision-making and patient care, ultimately increasing accessibility to healthcare services across the country.
  • Integration of AI in Diagnostics:The demand for AI-driven diagnostic tools is expected to rise, with an estimated market value of $350 million in future. This presents an opportunity for healthcare providers to adopt AI technologies that enhance diagnostic accuracy and speed. By leveraging AI analytics, healthcare facilities can improve patient outcomes and streamline operations, addressing the growing need for efficient healthcare solutions in Vietnam.

Scope of the Report

SegmentSub-Segments
By Type

Descriptive Analytics

Predictive Analytics

Prescriptive Analytics

By Component

Software

Services

By Delivery Model

On-Demand

On-Premises

By Application

Research and Development

Sales and Marketing

Regulatory Compliance

Supply Chain Analytics

Pharmacovigilance

By End-User

Pharmaceutical and Biotechnology Companies

Medical Device Companies

Academic Institutions and Research Organizations

Contract Research Organizations

By Region

Northern Vietnam

Central Vietnam

Southern Vietnam

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health, Ministry of Science and Technology)

Pharmaceutical Companies

Biotechnology Firms

Healthcare Providers and Hospitals

Medical Device Manufacturers

Health Insurance Companies

Data Analytics and AI Technology Providers

Players Mentioned in the Report:

IQVIA

Oracle

Accenture

Cognizant

Wipro

Thermo Fisher Scientific

Illumina

Invitae

Siemens Healthineers

SAP

Infosys

FujiFilm

VinBigData

FPT Corporation

Viettel Group

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Vietnam AI Life Science Analytics Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Vietnam AI Life Science Analytics Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Vietnam AI Life Science Analytics Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for personalized medicine
3.1.2 Advancements in AI technologies
3.1.3 Government support for healthcare innovation
3.1.4 Rising healthcare expenditure

3.2 Market Challenges

3.2.1 Data privacy concerns
3.2.2 High implementation costs
3.2.3 Lack of skilled workforce
3.2.4 Regulatory hurdles

3.3 Market Opportunities

3.3.1 Expansion of telemedicine services
3.3.2 Integration of AI in diagnostics
3.3.3 Collaborations with tech companies
3.3.4 Growth in health data analytics

3.4 Market Trends

3.4.1 Increasing use of machine learning algorithms
3.4.2 Shift towards cloud-based solutions
3.4.3 Focus on real-time data analytics
3.4.4 Rise of patient-centric healthcare models

3.5 Government Regulation

3.5.1 Data protection laws
3.5.2 Healthcare technology standards
3.5.3 AI ethics guidelines
3.5.4 Approval processes for AI tools

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Vietnam AI Life Science Analytics Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Vietnam AI Life Science Analytics Market Segmentation

8.1 By Type

8.1.1 Descriptive Analytics
8.1.2 Predictive Analytics
8.1.3 Prescriptive Analytics

8.2 By Component

8.2.1 Software
8.2.2 Services

8.3 By Delivery Model

8.3.1 On-Demand
8.3.2 On-Premises

8.4 By Application

8.4.1 Research and Development
8.4.2 Sales and Marketing
8.4.3 Regulatory Compliance
8.4.4 Supply Chain Analytics
8.4.5 Pharmacovigilance

8.5 By End-User

8.5.1 Pharmaceutical and Biotechnology Companies
8.5.2 Medical Device Companies
8.5.3 Academic Institutions and Research Organizations
8.5.4 Contract Research Organizations

8.6 By Region

8.6.1 Northern Vietnam
8.6.2 Central Vietnam
8.6.3 Southern Vietnam

9. Vietnam AI Life Science Analytics Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Year of Establishment
9.2.3 Revenue (USD Million)
9.2.4 Revenue Growth Rate (CAGR %)
9.2.5 Market Share (%)
9.2.6 Geographic Presence
9.2.7 Product Portfolio
9.2.8 Strategic Partnerships
9.2.9 Recent Acquisitions
9.2.10 Key Competitive Advantages

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 IQVIA
9.5.2 Oracle
9.5.3 Accenture
9.5.4 Cognizant
9.5.5 Wipro
9.5.6 Thermo Fisher Scientific
9.5.7 Illumina
9.5.8 Invitae
9.5.9 Siemens Healthineers
9.5.10 SAP
9.5.11 Infosys
9.5.12 FujiFilm
9.5.13 VinBigData
9.5.14 FPT Corporation
9.5.15 Viettel Group

10. Vietnam AI Life Science Analytics Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health
10.1.2 Ministry of Science and Technology
10.1.3 Ministry of Finance
10.1.4 Others

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Healthcare Infrastructure
10.2.2 Research and Development
10.2.3 IT Infrastructure
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Hospitals
10.3.2 Research Institutions
10.3.3 Pharmaceutical Companies
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Training and Support Needs
10.4.2 Technology Infrastructure
10.4.3 Regulatory Compliance
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Performance Metrics
10.5.2 User Feedback
10.5.3 Scalability Potential
10.5.4 Others

11. Vietnam AI Life Science Analytics Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-Ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-Sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-Term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity Planning
15.2.2 Milestone Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from Vietnamese government agencies and health organizations
  • Review of academic publications and white papers on AI applications in life sciences
  • Examination of market trends and forecasts from reputable market research firms

Primary Research

  • Interviews with key opinion leaders in the AI and life sciences sectors
  • Surveys targeting healthcare professionals and data scientists in Vietnam
  • Focus group discussions with stakeholders from biotech firms and research institutions

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including government and industry reports
  • Triangulation of insights from primary interviews with secondary data trends
  • Sanity checks conducted through expert panel reviews and feedback sessions

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of market size based on national healthcare expenditure and AI investment trends
  • Segmentation of the market by application areas such as diagnostics, drug discovery, and personalized medicine
  • Incorporation of government initiatives promoting AI in healthcare and life sciences

Bottom-up Modeling

  • Data collection from leading AI life science companies regarding their revenue and growth rates
  • Estimation of market penetration rates for AI technologies in various life science applications
  • Volume and pricing analysis based on service offerings and product types

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating variables such as healthcare digitization and AI adoption rates
  • Scenario modeling based on potential regulatory changes and technological advancements
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Healthcare AI Applications150Healthcare Administrators, AI Specialists
Biotechnology Research and Development100Biotech Researchers, Lab Managers
Pharmaceutical AI Integration80Pharmaceutical Executives, Data Analysts
Clinical Data Analytics70Clinical Researchers, Data Scientists
AI in Diagnostics90Diagnostic Lab Managers, Medical Technologists

Frequently Asked Questions

What is the current value of the Vietnam AI Life Science Analytics Market?

The Vietnam AI Life Science Analytics Market is valued at approximately USD 85 million, reflecting significant growth driven by the adoption of AI technologies in healthcare, personalized medicine demand, and increased healthcare expenditure in the region.

What are the key drivers of growth in the Vietnam AI Life Science Analytics Market?

Which cities are leading in the Vietnam AI Life Science Analytics Market?

What is the role of the Vietnamese government in promoting AI in healthcare?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022